相关实验视频
Updated: May 20, 2025
06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
21.8K
类似病毒的粒子:一个多功能和有效的疫苗平台
Martin F Bachmann1, Pierre van Damme2, Florian Lienert3
1Department of Immunology, University Hospital of Bern, Switzerland; University of Oxford, UK.
Expert review of vaccines
|May 19, 2025
概括
病毒样颗粒 (VLP) 为传统疫苗提供了更安全的替代方案. 本综述强调了它们的结构,制造和成功的临床应用,为未来的VLP疫苗开发铺平了道路.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
- 病毒学 病毒学
背景情况:
- 传统疫苗面临的局限性包括免疫性降低和安全问题.
- 病毒样颗粒 (VLP) 已成为一个有前途的替代疫苗平台.
- VLP模仿本地病毒,但没有传染性,解决了传统疫苗的缺点.
研究的目的:
- 为提供病毒样粒子 (VLP) 疫苗技术的概述.
- 讨论用于疫苗开发的VLP的结构,设计和制造.
- 审查已批准和正在研究的VLP疫苗的临床疗效和安全性.
主要方法:
- 对VLP疫苗开发和临床数据的文献综述.
- 对VLP结构,组装和生产方法的分析.
- 对针对各种病原体的VLP疫苗的临床试验结果的摘要.
主要成果:
- VLP是自组装的,非传染性病毒蛋白结构.
- 已批准的VLP疫苗显示出显著的有效性和安全性.
- 针对呼吸道同胞病毒和人类甲肺病毒,VLP疫苗正在开发的后期阶段.
结论:
- VLP 代表了用于疫苗开发的多功能和有效平台.
- 它们的安全性和免疫性特征使它们对全球免疫接种具有吸引力.
- 在VLP技术的进步承诺高效的未来疫苗.
更多相关视频
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.5K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.5K
相关概念视频
00:56Viral Structure
61.4K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
61.4K
01:51Vaccinations
43.1K
Overview
43.1K